ImmuCell Co. (NASDAQ:ICCC) Short Interest Update

ImmuCell Co. (NASDAQ:ICCC) was the target of a large growth in short interest in November. As of November 15th, there was short interest totalling 23,600 shares, a growth of 490.0% from the October 31st total of 4,000 shares. Currently, 0.4% of the company’s stock are sold short. Based on an average daily trading volume, of 34,600 shares, the days-to-cover ratio is presently 0.7 days.

ImmuCell Stock Down 1.1 %

Shares of ICCC traded down $0.04 during midday trading on Wednesday, reaching $3.66. 15,102 shares of the stock were exchanged, compared to its average volume of 18,976. ImmuCell has a 52 week low of $3.34 and a 52 week high of $5.59. The company has a current ratio of 3.11, a quick ratio of 1.44 and a debt-to-equity ratio of 0.36. The company’s 50 day moving average is $3.61 and its two-hundred day moving average is $3.97. The company has a market capitalization of $32.61 million, a P/E ratio of -7.40 and a beta of 0.56.

About ImmuCell

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E.